标准剂量皮内流感疫苗在HIV感染及未感染男性中诱导的细胞免疫应答与肌内疫苗相似
该研究在79例HIV感染男性和79例HIV未感染男性中比较标准剂量皮内与肌内流感疫苗,评估血清学、抗原特异性B细胞及细胞因子分泌T细胞应答。结果显示接种途径不影响抗体、B细胞或T细胞应答,但CD4+ T细胞计数<200 cells/μL者IgG记忆B细胞应答严重受损。
要点
- 皮内与肌内接种途径对HIV感染及未感染男性的抗体和细胞免疫应答无差异。
- CD4+ T细胞计数<200 cells/μL者接种后IgG记忆B细胞应答严重受损。
- CD4+ T细胞计数<200 cells/μL的HIV感染者需探索被动免疫策略。
核心结论
- 标准剂量皮内与肌内流感疫苗在HIV感染及未感染男性中诱导的抗体、抗体亲和力、T细胞及B细胞应答无差异。
- CD4+ T细胞计数<200 cells/μL的HIV感染者对流感疫苗的血清学和细胞免疫应答受损。
研究设计与样本
- 研究纳入79例HIV感染男性和79例HIV未感染男性,比较标准剂量皮内与肌内流感疫苗接种后的免疫应答。
- 评估指标包括血清学、抗原特异性B细胞及白细胞介素2、干扰素γ、肿瘤坏死因子α分泌T细胞应答。
- 临床试验注册号NCT01538940。
主要发现
- 接种途径不影响免疫球蛋白A和免疫球蛋白G浆母细胞或记忆B细胞应答。
- CD4+ T细胞计数<200 cells/μL组IgA和IgG浆母细胞或记忆B细胞应答严重受损。
- 接种后第28天IgG记忆B细胞频率在HIV未感染组最高,其次为CD4+ T细胞计数≥200 cells/μL组,CD4+ T细胞计数<200 cells/μL组最低。
- 接种途径不影响接种后不同时间点测得的CD4+或CD8+ T细胞应答。
临床怎么用
- 标准剂量皮内流感疫苗可作为肌内接种的替代途径,两者诱导的免疫应答相似。
- 对CD4+ T细胞计数<200 cells/μL的HIV感染者,应考虑探索被动免疫策略以提供保护。
局限性
- 研究仅纳入男性受试者,结果可能不适用于女性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Human immunodeficiency virus (HIV)-infected persons are at a higher risk of severe influenza. Although we have shown that a standard-dose intradermal influenza vaccine versus a standard-dose intramuscular influenza vaccine does not result in differences in hemagglutination-inhibition titers in this population, a comprehensive examination of cell-mediated immune responses remains lacking. METHODS: Serological, antigen-specific B-cell, and interleukin 2-, interferon γ-, and tumor necrosis factor α-secreting T-cell responses were assessed in 79 HIV-infected men and 79 HIV-uninfected men. RESULTS: The route of vaccination did not affect the immunoglobulin A and immunoglobulin G (IgG) plasmablast or memory B-cell response, although these were severely impaired in the group with a CD4+ T-cell count of <200 cells/μL. The frequencies of IgG memory B cells measured on day 28 after vaccination were highest in the HIV-uninfected group, followed by the group with a CD4+ T-cell count of ≥200 cells/μL and the group with a CD4+ T-cell count of <200 cells/μL. The route of vaccination did not affect the CD4+ or CD8+ T-cell responses measured at various times after vaccination. CONCLUSIONS: The route of vaccination had no effect on antibody responses, antibody avidity, T-cell responses, or B-cell responses in HIV-infected or HIV-uninfected subjects. With the serological and cellular immune responses to influenza vaccination being impaired in HIV-infected individuals with a CD4+ T-cell count of <200 cells/μL, passive immunization strategies need to be explored to protect this population. CLINICAL TRIALS REGISTRATION: NCT01538940.
引用
- Amoah S, Mishina M, Praphasiri P, et al. Standard-Dose Intradermal Influenza Vaccine Elicits Cellular Immune Responses Similar to Those of Intramuscular Vaccine in Men With and Those Without HIV Infection. J Infect Dis. 2019. PMID: 31045222. doi:10.1093/infdis/jiz205
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。